Literature DB >> 7744197

Predictors for nocturnal hypoxaemia (mean SaO2 < 90%) in normoxic and mildly hypoxic patients with COPD.

P J Vos1, H T Folgering, C L van Herwaarden.   

Abstract

Detection of nocturnal hypoxaemia, defined as a mean arterial oxygen saturation below 90%, in normoxic or mildly hypoxic chronic obstructive pulmonary disease (COPD) patients seems clinically relevant, since this feature may precede pulmonary hypertension. Nocturnal studies are expensive and time-consuming procedures. The current study investigates to what extent it is possible to predict nocturnal hypoxaemia from daytime parameters. Forty two COPD patients with a daytime arterial oxygen tension (PaO2) above 8 kPa participated. Nocturnal oxygenation, daytime blood gas values, and ventilatory responses to hypercapnia were measured. In 10 patients, enough desaturations occurred to qualify as nocturnal hypoxaemia. They had a significantly lower daytime PaO2 value, and a lower steady-state hypercapnic ventilatory response. They also smoked more often, and complained about daytime sleepiness. Multiple linear regression analysis demonstrated that daytime PaO2 (32%) was the best independent predictor. Sleepiness (12%), and number of cigarettes smoked (5%) also contributed independently, but in a minor way. Patients with a high daytime PaO2 (> 11 kPa) did not develop nocturnal hypoxaemia. The hypercapnic ventilatory response was used to distinguish nocturnal hypoxaemic from normoxaemic patients. Only patients with a low response (< 3.5 l.min-1.kPa-1) appeared to run a risk of developing nocturnal hypoxaemia. The sensitivity of this test was 80%, and the specificity 70%. It is concluded that daytime PaO2, hypercapnic ventilatory response and sleepiness are helpful in predicting nocturnal hypoxaemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744197     DOI: 10.1183/09031936.95.08010074

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Sleep and Obstructive Lung Diseases.

Authors:  Michael E Ezzie; Jonathan P Parsons; John G Mastronarde
Journal:  Sleep Med Clin       Date:  2008-12

2.  Overnight prescription of oxygen in long term oxygen therapy: time to reconsider the guidelines?

Authors:  M Nisbet; T Eaton; C Lewis; W Fergusson; J Kolbe
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

3.  Oxyhemoglobin Saturation Overshoot Following Obstructive Breathing Events Mitigates Sleep Apnea-Induced Glucose Elevations.

Authors:  Luu V Pham; Alan R Schwartz; Jonathan C Jun
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-23       Impact factor: 5.555

Review 4.  Respiratory disorders during sleep in chronic obstructive pulmonary disease.

Authors:  Oreste Marrone; Adriana Salvaggio; Giuseppe Insalaco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

5.  Obstructive sleep apnea and cardiovascular risk.

Authors:  Punginathn Dorasamy
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

6.  Pulmonary rehabilitation and sleep quality: a before and after controlled study of patients with chronic obstructive pulmonary disease.

Authors:  Lucy M McDonnell; Lauren Hogg; Lynn McDonnell; Patrick White
Journal:  NPJ Prim Care Respir Med       Date:  2014-07-10       Impact factor: 2.871

Review 7.  Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classification, pathophysiology and clinical outcomes.

Authors:  Rebecca F D'Cruz; Patrick B Murphy; Georgios Kaltsakas
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.